The patient with hormone-refractory prostate cancer: determining who, when, and how to treat.

The patient with hormone-refractory prostate cancer: determining who, when, and how to treat.

Item
http://www.wikidata.org/entity/Q35640651
Reduced tumor growth in vivo and increased c-Abl activity in PC3 prostate cancer cells overexpressing the Shb adapter protein.Lipid nanoparticle siRNA systems for silencing the androgen receptor in human prostate cancer in vivo.Castration-resistant prostate cancer: systemic therapy in 2012Prostate cancer and the principles of hormone therapy.Effects of bortezomib in sensitizing human prostate cancer cell lines to NK-mediated cytotoxicity.To die or to survive, a fatal question for the destiny of prostate cancer cells after androgen deprivation therapy.Targeting the relaxin hormonal pathway in prostate cancer.Mitotic arrest induced in human DU145 prostate cancer cells in response to KHC-4 treatment.A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer.Transgelin induces apoptosis of human prostate LNCaP cells through its interaction with p53.Chronic administration of valproic acid inhibits PC3 cell growth by suppressing tumor angiogenesis in vivo.2-Methoxyestradiol-induced apoptosis in prostate cancer cells requires Smad7.Inactivation of Id-1 in prostate cancer cells: A potential therapeutic target in inducing chemosensitization to taxol through activation of JNK pathway.
P2860

The patient with hormone-refractory prostate cancer: determining who, when, and how to treat.

Item
http://www.wikidata.org/entity/Q35640651
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
The patient with hormone-refra ...... g who, when, and how to treat.
@ast
The patient with hormone-refra ...... g who, when, and how to treat.
@en
type
label
The patient with hormone-refra ...... g who, when, and how to treat.
@ast
The patient with hormone-refra ...... g who, when, and how to treat.
@en
prefLabel
The patient with hormone-refra ...... g who, when, and how to treat.
@ast
The patient with hormone-refra ...... g who, when, and how to treat.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P478
P577
P698
P356
P1433
P1476
The patient with hormone-refra ...... g who, when, and how to treat.
@en
P2093
P304
P31
P356
10.1016/J.UROLOGY.2003.09.005
P407
P478
P577
P698